The DOI matches its Crossref record; 34 of the 36 references it cites were found in a registry or an index.
Age-Related Macular Degeneration Is Associated with Incident Myocardial Infarction among Elderly Americans
Abstract
Objective To investigate whether age-related macular degeneration (AMD) is associated with the development of myocardial infarction (MI) among elderly Americans.Design Population-based cross-sectional and cohort study.Participants Five percent random sample of 2000 to 2003 Medicare enrollees.Methods The cross-sectional study included the first 2-year (2000 and 2001) enrollees who were aged > or =65 years (n = 1,519,086). The cohort study included only baseline MI-free enrollees (n = 1445677).Main outcome measures Chronic conditions (AMD and type, history of MI, hypertension, and diabetes) were defined based on any occurrence of relevant International Classification of Diseases 9 codes in relevant diagnosis fields of the baseline Medicare claim files. A total of 56611 incident MI cases were identified from the follow-up data (2002 and 2003).Results Baseline mean age was 76 years, with 60% women and 88% whites. The prevalence of neovascular AMD was 2.2% (2.3% in women vs. 1.7% in men and 2.3% in whites vs. 1.2% in blacks; P<0.01 for both gender and race differences). The prevalence of nonneovascular AMD was 8.8% (9.9% in women vs. 7.3% in men and 9.5% in whites vs. 4.3% in blacks; P<0.01 for both gender and race differences). Baseline age-, gender-, and race-adjusted prevalences of hypertension, diabetes, and history of MI were 75%, 33%, and 5.00%, respectively, in the neovascular AMD group. In contrast, they were 73%, 27%, and 4.68% in the nonneovascular AMD group, and 65%, 25%, and 4.54% in the non-AMD group (P<0.01 for comparing the prevalence in neovascular and nonneovascular AMD vs. non-AMD groups). Prospectively, baseline age-, gender-, race-, hypertension-, and diabetes-adjusted 2-year incident odds ratios and 95% confidence intervals of MI associated with AMD are 1.19 (1.16-1.22) for all persons with AMD, 1.26 (1.20-1.33) for neovascular AMD, and 1.18 (1.14-1.21) for nonneovascular AMD.Conclusions AMD is associated with older age, female gender, being white, and having a history of MI, hypertension, and diabetes. Furthermore, presence of AMD, especially neovascular AMD, is prospectively associated with a higher risk of incident MI. These findings, if confirmed by other studies that control for smoking and other lifestyle covariables, suggest the possibility of shared common antecedents between MI and AMD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Using Medicare data—which could be confounded by smoking—patients with age-related macular degeneration were shown to have an increased risk of myocardial infarction.76”
From Age-related macular degeneration (2008) · cites this paper as [76]
Citations
Cites
Prevalence of Age-Related Macular Degeneration in the United States
The Eye Diseases Prevalence Research Group* (2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.564 · Cited by 2,774
Leibowitz, H. M., Krueger, D. E., Maunder, L. R., Milton, R. C., KINI, M. M., Kahn, H. A., Nickerson, R. J., Pool, J., Colton, T., Ganley, J. P., et al. (1980) · PubMed · Cited by 1,250
Risk factors for age-related macular degeneration
Smith, W., Assink, J., Klein, R., Mitchell, P., Klaver, C. C. W., Klein, B. E. K., Hofman, A., Jensen, S., Wang, J. J., & de Jong, P. T. V. M. (2001) · Ophthalmology · doi:10.1016/s0161-6420(00)00580-7 · Cited by 1,071
Self-citationDietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration
Seddon, J. M. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03520180037032 · Cited by 993
Mutation of the Stargardt Disease Gene ( ABCR ) in Age-Related Macular Degeneration
Allikmets, R. L., Shroyer, N. F., Singh, N., Seddon, J. M., Lewis, R. A., Bernstein, P. S., Peiffer, A. P., Zabriskie, N. A., Li, Y., Hutchinson, A. A., et al. (1997) · Science · doi:10.1126/science.277.5333.1805 · Cited by 879
The Framingham Eye Study. I. Outline and major prevalence findings.
Kahn, H. A., Leibowitz, H., Ganley, J., Kini, M., Colton, T., Nickerson, R. S., & Dawber, T. (1977) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112428 · Cited by 821
The Prevalence of Age-related Maculopathy in the Rotterdam Study
Vingerling, J. R., Dielemans, I., Hofman, A., Grobbee, D. E., Hijmering, M., Kramer, C. F. L., & de Jong, P. T. V. M. (1995) · Ophthalmology · doi:10.1016/s0161-6420(95)31034-2 · Cited by 815
Accuracy of ICD-9-CM Codes for Identifying Cardiovascular and Stroke Risk Factors
Birman-Deych, E., Waterman, A. D., Yan, Y., Nilasena, D. S., Radford, M. J., & Gage, B. F. (2005) · Medical Care · doi:10.1097/01.mlr.0000160417.39497.a9 · Cited by 723
Risk factors associated with age-related macular degeneration
(2000) · Ophthalmology · doi:10.1016/s0161-6420(00)00409-7 · Cited by 633
Senile macular degeneration: a case-control study
HYMAN, L. G., LILIENFELD, A. M., FERRIS, F. L., & FINE, S. L. (1983) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113629 · Cited by 587
Flagged first, then by citations
2 of the 36 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–128 of 128
Yan, Y. (2015) · Pakistan Journal of Pharmaceutical Sciences · doi:10.36721/pjps/28/4(sup)/2015/265/1481-1484 · Cited by 4
Liang, C., & Wang, N. (2022) · Computational and Mathematical Methods in Medicine · doi:10.1155/2022/3135100 · Cited by 3
RetractedGudauskienė, G., Vilkevičiūtė, A., Gedvilaitė, G., Liutkevičienė, R., & Žaliūnienė, D. (2022) · Life · doi:10.3390/life12071038 · Cited by 3
Gao, X., Wang, Y., Hou, H., Lyu, Y., Wang, H., Yao, L.-B., Zhang, J., Cao, F., & Wang, Y. (2016) · International Journal of Ophthalmology · doi:10.18240/ijo.2016.04.07 · Cited by 3
Wang, Y., Liang, Y., Seth, I., Wu, G., Du, Z., Huang, Y., Shang, X., Liu, S., Hu, Y., Fang, Y., et al. (2023) · Asia-Pacific Journal of Ophthalmology · doi:10.1097/apo.0000000000000612 · Cited by 3
Dégénérescence maculaire liée à l’âge et risque d’accident vasculaire cérébral
Biousse, V., Bousser, M., & Gaudric, A. (2008) · Journal Français d Ophtalmologie · doi:10.1016/s0181-5512(08)70343-7 · Cited by 3
Macular Degeneration and Heart Disease
Liew, G., Wang, J. J., & Wong, T. Y. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2007.04.036 · Cited by 3
AMD: Epidemiology and Risk Factors
Khan, J. C. (2013) · InTech eBooks · doi:10.5772/55234 · Cited by 2
Cardiovascular Disease and Age-Related Macular Degeneration
Smith, R. T., & Rosenfeld, P. J. (2026) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2026.05.003 · Cited by 1
Age-Related Macular Degeneration and Mortality in the Age-Related Eye Disease Study (AREDS)
Joslin, C. E., Vajaranant, T. S., & Ulanski, L. (2016) · Ophthalmology Retina · doi:10.1016/j.oret.2016.09.004 · Cited by 1
Likhvantseva, V. G., Gevorgyan, A. S., Kapkova, S. G., Рычкова, С. И., & Borisenko, T. E. (2024) · Ophthalmology in Russia · doi:10.18008/1816-5095-2024-1-117-127 · Cited by 1
Kiel, C., Weber, B. H. F., & Graßmann, F. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-75402-4_30 · Cited by 1
Cheng, Q. (2022) · Digital Archive @ GSU · doi:10.57709/5563806 · Cited by 1
Age-Related Macular Degeneration, Cardiovascular Disease and StrokePreprint
Ledesma‐Gil, G., Otero-Marquez, O., Alauddin, S., Tong, Y., Wei, W., Tai, K. W., Lloyd, H. O., Koci, M., Ye, C., Pillai, C., et al. (2021) · medRxiv · doi:10.1101/2021.09.13.21263389 · Cited by 1
Thomson, R. J., Chazaro, J., Otero-Marquez, O., Ledesma‐Gil, G., Tong, Y., Coughlin, A. C., Teibel, Z. R., Alauddin, S., Tai, K. W., Lloyd, H. O., et al. (2021) · medRxiv · doi:10.1101/2021.09.27.21263712 · Cited by 1
Seguridad sistémica del tratamiento anti-VEGF
Cabrera, L. F. (2010) · Elsevier eBooks · doi:10.1016/b978-84-8086-706-1.50022-5
Čiumbaraitė, R. (2013) · Lithuanian University of Health Sciences
Update: A 76-Year-Old Man With Macular Degeneration
Farag, N. (2008) · JAMA · doi:10.1001/jama.300.1.91
Update on Age-Related Macular Degeneration
Hurwitz, J. J., & Steinbach, M. J. (2009)
Liutkevičienė, R., Čiumbaraitė, R., & Banevičius, M. (2016) · Acta medica Lituanica · doi:10.6001/actamedica.v22i4.3238
Low-level night-time light therapy for age-related macular degeneration
Robinson, D. G. (2017) · ORCA Online Research @Cardiff (Cardiff University)
Fraunfelder, F. “. T., & Fraunfelder, F. “. W. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-65375-6.00018-9
Schäfer, K. (2012) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-1505
Variations in Using Diagnosis Codes for Defining Age-Related Macular Degeneration Cohorts
Kalaw, F. G. P., Chen, J., & Baxter, S. L. (2024) · Informatics · doi:10.3390/informatics11020028
Molecular Genetics of Age-related Macular Degeneration
Seitsonen, S. (2008) · Työväentutkimus Vuosikirja
Implants à base de PLGA pour la libération oculaire
Bode, C. (2019) · theses.fr (ABES) · doi:10.70675/db064711z80cez456aza9edzb4509e94b78b
Insights into age-related macular degeneration
Lankry, P., Loewenstein, A., & Trivizki, O. (2026) · Handbook of clinical neurology · doi:10.1016/b978-0-443-22212-2.00020-3
Reticular pseudodrusen load is associated with an increased risk of stroke
Schwartz, R., Olvera‐Barrios, A., Warwick, A., Khalid, H., Phatak, S., Jhingan, M., de Vente, C., Valmaggia, P., Liakopoulos, S., Ouyang, Y., et al. (2026) · BMJ Open Ophthalmology · doi:10.1136/bmjophth-2025-002481
Metadata
- Authors
- Duan, Y., Mo, J., Klein, R., Scott, I. U., Lin, H.-M., Caulfield, J., Patel, M., & Liao, D.
- Affiliations
- Pennsylvania State University (US)
- Pfizer (United States) (US)
- University of Wisconsin–Madison (US)
- Corresponding author
- Liao, Duanping
- Venue
- Ophthalmology
- Publisher
- Elsevier BV
- Published
- 2007-04
- Volume
- 114
- Issue
- 4
- Pages
- 732-737
- ISSN
- 0161-6420 (ISSN-L)
- OpenAlex
- W2059277692
- Cited by
- 128
- References
- 36
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 5 · 2023: 3 · 2022: 6 · 2021: 4 · 2020: 4 · 2019: 3 · 2018: 5 · 2017: 10 · 2016: 8 · 2015: 10 · 2014: 9 · 2013: 8 · 2012: 9
- FWCI
- 6.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Ophthalmology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Pfizer
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Keywords
- age-related macular degeneration, myocardial infarction, neovascular AMD, cardiovascular risk, older adults, hypertension, diabetes mellitus, chronic disease, sex differences, racial differences, Medicare enrollees, comorbidity burden
- MeSH terms
- Age Factors, Aged, Aged, 80 and over, Cross-Sectional Studies, Female, Humans, Hypertension, Macular Degeneration, Male, Myocardial Infarction, Prospective Studies, Risk Factors, Sex Factors, United States, Prevalence, Odds Ratio, White People, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review